Turning pro-tumor inflammation into target opportunity: Development of an IL1RAP ADC for solid tumor treatment
用户bPHFPja4LacU
1个月前
92
10
已关闭
DOI:
文献链接:
其他信息:
Y Chen, M Gray, PM Treuting, C Miller…
Cancer …, 2025
aacrjournals.org
… of IL1RAP on many solid tumor indications, including melanoma, non-small cell lung
cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC) and esophageal cancer, …

